Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
Shunsuke Mori16
Japon Sauf Shunsuke Mori" 991
Shunsuke Mori Sauf Japon" 4
Japon Et Shunsuke Mori 12
Japon Ou Shunsuke Mori 1007
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000902 Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
001864 Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
001B66 Shunsuke Mori [Japon] ; Yukinori Koga [Japon]Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
002047 Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
002145 Shunsuke Mori [Japon] ; Mineharu Sugimoto [Japon]Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
002847 Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Yukihiro Akeda [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Yoshiki Shiohira [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
003417 Shunsuke Mori [Japon] ; Kaoru Terada ; Yukitaka UekiTocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
003469 Shunsuke Mori [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Akio Mimori ; Norihiro Nishimoto ; Sadatomo Tasaka ; Kazuhiro Hatta ; Hidekazu Matsushima ; Shunji Kaise ; Atsushi Kaneko ; Shigeki Makino ; Seiji Minota ; Takashi Yamada ; Shinobu Akagawa ; Atsuyuki KurashimaRadiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.
003565 Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
003907 Shunsuke Mori [Japon] ; Yukitaka UekiPrimary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab.
003958 Hideto Kameda [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Shunsuke Mori ; Yuji Yoshida ; Noboru Takayanagi ; Hirofumi Taki ; Yoshinori Hasegawa ; Kazuhiro Hatta ; Hisashi Yamanaka ; Makoto Dohi ; Shu Hashimoto ; Hidehiro Yamada ; Shinichi Kawai ; Tsutomu Takeuchi ; Kazuhiro Tateda ; Hajime GotoClinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
003D99 Shunsuke Mori [Japon] ; Jun Hirose [Japon] ; Kensuke Yonemura [Japon]Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021